Reply to Vargas and Farhat: <i>Mycobacterium tuberculosis glpK</i> mutants in human tuberculosis.

Safi, Hassan; Sherman, David R; Dick, Thomas; Alland, David

Reply to Vargas and Farhat: Mycobacterium tuberculosis glpK mutants in human tuberculosis.

Safi, Hassan; Sherman, David R; Dick, Thomas; Alland, David.

Afiliação

Safi H; Center for Emerging Pathogens, New Jersey Medical School, Rutgers University, Newark, NJ 07103.
Sherman DR; Department of Medicine, New Jersey Medical School, Rutgers University, Newark, NJ 07103.
Dick T; Center for Infectious Disease, Seattle Children's Hospital, Seattle, WA 98105.
Alland D; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110.

Proc Natl Acad Sci U S A ; 117(8): 3913-3914, 2020 02 25.

Article em En | MEDLINE | ID: mdl-32075921

Assuntos

Mycobacterium tuberculosis/efeitos dos fármacos; Tuberculose; Antituberculosos; Tolerância a Medicamentos; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google